Ton Rabelink

The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis

P. V. D. van der Boog, D. van der Woude, Y. K. O. Teng, 2023, Clinical Kidney Journal.

A novel method for high-throughput detection and quantification of neutrophil extracellular traps reveals ROS-independent NET release with immune complexes.

C. van Kooten, T. Kraaij, Y. Teng, 2016, Autoimmunity reviews.

Using an artificial intelligence tool incorporating natural language processing to identify patients with a diagnosis of ANCA-associated vasculitis in electronic health records

R. Knevel, E. Penne, Y. K. O. Teng, 2023, Comput. Biol. Medicine.

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy

F. Bemelman, L. Trouw, A. D. de Vries, 2024, Kidney international reports.

TAC-TIC use of tacrolimus-based regimens in lupus nephritis

A. D. de Craen, T. Rabelink, T. Huizinga, 2016, Lupus Science & Medicine.

Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients

A. D. de Vries, C. van Kooten, M. V. van Hemert, 2023, Kidney international reports.